- Garnering Investor Attention: JMP Inititates With BUY And $8 PT
- LOM Initiates Coverage On Two Regenerative Medicine Companies
- AxoGen, Inc. Announces Release Dates For 2012 Third Quarter Results And Conference Call
- AxoGen, Inc. Reports Record Second Quarter 2012 Revenues
- Don't Become 'Unnerved' About Regenerative Medicine
Cockrell Group
Cockrell Group
Send Message
Cockrell Group
Stop FollowingCockrell Group
ABOUT
The Cockrell Group, Inc. is a strategic capital markets development firm focused on small-to-midcap companies. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in various areas, including private and pre-IPO activity, mergers and acquisitions, bankruptcy, executive transitions, activist shareholders, hostile takeovers, and downsizing, as well as manages events.
SNAPSHOT
- Description: IR professional. Trading frequency: Not Trading
- Interests: Stocks - long
BLOG
Currently, there are no blog details for Cockrell Group.
Book
Currently, there are no book details for Cockrell Group.
LATEST STOCKTALK
more »
JMP Securities initiates coverage on $AXGN.OB shares with an OUTPERFORM rating and an $8.00 share price.
Apr 18, 2013
Latest Comments
more »
- No, the Avance nerve graft ... on This Regenerative Nerve Company's Growth Contin...
Latest comments on Cockrell's Articles
LATEST ARTICLES & INSTAPOSTS
more »

